Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
出版年份 2019 全文链接
标题
Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
作者
关键词
-
出版物
Frontiers in Immunology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-09-06
DOI
10.3389/fimmu.2019.01990
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
- (2019) Fernando C. Fervenza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT
- (2018) Sarah Brown et al. HEALTH TECHNOLOGY ASSESSMENT
- Rituximab in refractory myasthenia gravis: extended prospective study results
- (2018) Grayson Beecher et al. MUSCLE & NERVE
- IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy
- (2018) Giacomo Quattrocchio et al. Oncotarget
- Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic Syndrome
- (2018) Biswanath Basu et al. JAMA Pediatrics
- Responsiveness to low-dose rituximab in refractory generalized myasthenia gravis
- (2017) Sisi Jing et al. JOURNAL OF NEUROIMMUNOLOGY
- Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial
- (2017) Zahra Nikoo et al. JOURNAL OF NEUROLOGY
- First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
- (2017) Pascal Joly et al. LANCET
- Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome
- (2017) Simon J. Bowman et al. Arthritis & Rheumatology
- A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study)
- (2016) Marc Michel et al. AMERICAN JOURNAL OF HEMATOLOGY
- Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravis
- (2016) Christine Lebrun et al. JOURNAL OF NEUROIMMUNOLOGY
- A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction
- (2016) Richard A. Lafayette et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
- (2016) Karine Dahan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial
- (2016) Duncan Porter et al. LANCET
- Rituximab in refractory myasthenia gravis: a prospective, open-label study with long-term follow-up
- (2016) Dustin Anderson et al. Annals of Clinical and Translational Neurology
- Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
- (2016) Mika Komori et al. Annals of Clinical and Translational Neurology
- Rituximab for the Treatment of Patients with Autoimmune Hepatitis Who are Refractory or Intolerant to Standard Therapy
- (2016) Kelly W Burak et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders
- (2015) O. Boyman et al. ALLERGY
- Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysis
- (2015) I. Fleury et al. ANNALS OF ONCOLOGY
- Rituximab for IgG4-related disease: a prospective, open-label trial
- (2015) Mollie N Carruthers et al. ANNALS OF THE RHEUMATIC DISEASES
- Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years
- (2015) Motohisa Yamamoto et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
- (2015) Rachel B Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study
- (2015) Luca Quartuccio et al. JOURNAL OF AUTOIMMUNITY
- Randomized Controlled Trial of Rituximab in Patients With Graves' Orbitopathy
- (2015) Marius N. Stan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of B-Cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves' Orbitopathy: A Randomized Controlled Study
- (2015) Mario Salvi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial
- (2015) P. Ravani et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
- (2015) Waleed Ghanima et al. LANCET
- Treatment of Primary Sjögren Syndrome With Rituximab
- (2014) Valérie Devauchelle-Pensec et al. ANNALS OF INTERNAL MEDICINE
- MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study
- (2014) Charles Peterfy et al. ANNALS OF THE RHEUMATIC DISEASES
- An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial
- (2014) Edward M Vital et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease
- (2014) T. S. Uldrick et al. BLOOD
- Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study
- (2014) A.J. Kanwar et al. BRITISH JOURNAL OF DERMATOLOGY
- Effect of Rituximab on Serum Levels of Anti-C1q and Antineutrophil Cytoplasmic Autoantibodies in Refractory Severe Lupus Nephritis
- (2014) Jin Zhang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
- (2014) Kazumoto Iijima et al. LANCET
- Adverse reactions to biologic agents and their medical management
- (2014) Onur Boyman et al. Nature Reviews Rheumatology
- Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
- (2014) Loïc Guillevin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab for the Treatment of Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
- (2014) E. M. Miloslavsky et al. Arthritis & Rheumatology
- Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trial
- (2013) Xavier Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia
- (2013) S. Gudbrandsdottir et al. BLOOD
- A phase III randomized trial comparing glucocorticoid monotherapyversusglucocorticoid and rituximab in patients with autoimmune haemolytic anaemia
- (2013) Henrik Birgens et al. BRITISH JOURNAL OF HAEMATOLOGY
- Association of Serum B-Cell Activating Factor Level and Proportion of Memory and Transitional B Cells with Clinical Response after Rituximab Treatment of Bullous Pemphigoid Patients
- (2013) Russell P. Hall et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor–dependent idiopathic nephrotic syndrome
- (2013) Pietro Ravani et al. KIDNEY INTERNATIONAL
- Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis
- (2013) Feng Sun et al. MUSCLE & NERVE
- Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
- (2013) Ulrich Specks et al. NEW ENGLAND JOURNAL OF MEDICINE
- One-year follow-up of ankylosing spondylitis patients responding to rituximab treatment and re-treated in case of a flare
- (2012) In-Ho Song et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab in psoriatic arthritis: an exploratory evaluation
- (2012) Esther Jimenez-Boj et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome
- (2012) Doruk Erkan et al. ARTHRITIS AND RHEUMATISM
- Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial
- (2012) Chester V. Oddis et al. ARTHRITIS AND RHEUMATISM
- A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia
- (2012) D. M. Arnold et al. BLOOD
- Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome
- (2012) A. Magnasco et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Long-lasting treatment effect of rituximab in MuSK myasthenia
- (2012) J. Diaz-Manera et al. NEUROLOGY
- Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE
- (2011) Paul P Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: Results from a randomized controlled trial
- (2011) Maria W. Greenwald et al. ARTHRITIS AND RHEUMATISM
- A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis
- (2011) Michael C. Sneller et al. ARTHRITIS AND RHEUMATISM
- A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis
- (2011) S. De Vita et al. ARTHRITIS AND RHEUMATISM
- Short-Term Effects of Rituximab in Children with Steroid- and Calcineurin-Dependent Nephrotic Syndrome: A Randomized Controlled Trial
- (2011) P. Ravani et al. Clinical Journal of the American Society of Nephrology
- Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis
- (2011) Ekaterina I. Alexeeva et al. CLINICAL RHEUMATOLOGY
- Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
- (2011) K. Leiper et al. GUT
- Tubular Lesions Predict Renal Outcome in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis after Rituximab Therapy
- (2011) A. E. Berden et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab for the Treatment of IgG4-Related Disease
- (2011) Arezou Khosroshahi et al. MEDICINE
- Rituximab in anti-glomerular basement membrane disease
- (2011) Y. Shah et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Rituximab for severe myasthenia gravis - experience from five patients
- (2010) C. Lindberg et al. ACTA NEUROLOGICA SCANDINAVICA
- Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))
- (2010) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial
- (2010) P. P. Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial
- (2010) J. M. Meijer et al. ARTHRITIS AND RHEUMATISM
- Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: A twenty-four-week clinical trial
- (2010) I.-H. Song et al. ARTHRITIS AND RHEUMATISM
- Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease
- (2010) Arezou Khosroshahi et al. ARTHRITIS AND RHEUMATISM
- Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
- (2010) F. Zaja et al. BLOOD
- Pegylated interferon- , ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study
- (2010) F. Dammacco et al. BLOOD
- Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia
- (2010) Zhenyu Li et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Rituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study)
- (2010) Fereydoun DAVATCHI et al. International Journal of Rheumatic Diseases
- Efficacy and Safety of Retreatment in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors: Results from the SUNRISE Trial
- (2010) P. J. MEASE et al. JOURNAL OF RHEUMATOLOGY
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)
- (2010) A. Rubbert-Roth et al. RHEUMATOLOGY
- Repeated courses of rituximab in chronic ITP: Three different regimens
- (2009) Aisha Hasan et al. AMERICAN JOURNAL OF HEMATOLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis
- (2009) J Narvaez et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
- (2009) Clifton O. Bingham et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Rituximab for myasthenia gravis
- (2009) Karl Stieglbauer et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
- (2009) Dimitrios Daoussis et al. RHEUMATOLOGY
- Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate
- (2008) K Owczarczyk et al. ANNALS OF THE RHEUMATIC DISEASES
- Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study
- (2008) S Dass et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies
- (2008) E Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Successful treatment of refractory generalized myasthenia gravis with rituximab
- (2008) C. Lebrun et al. EUROPEAN JOURNAL OF NEUROLOGY
- Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients
- (2008) Isabel Illa et al. JOURNAL OF NEUROIMMUNOLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multicentric Castleman's disease treated with combination chemotherapy and rituximab in four HIV-positive men: A case series
- (2007) Alain Bestawros et al. AMERICAN JOURNAL OF HEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started